Top compounds associated with response to RP11-309L24.4


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.033 0.4
mRNA BRD-A02303741 CTRPv2 pan-cancer AAC 0.034 0.4
mRNA JQ-1 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.034 0.4
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.034 0.4
mRNA SR1001 CTRPv2 pan-cancer AAC 0.033 0.4
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.029 0.4
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.031 0.4
mRNA erastin CTRPv2 pan-cancer AAC 0.031 0.4
mRNA PF-4800567 hydrochloride CTRPv2 pan-cancer AAC -0.049 0.4
Download CSV